ProfileGDS4718 / 226072_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 84% 85% 77% 85% 83% 85% 83% 85% 84% 84% 84% 82% 81% 80% 83% 81% 84% 86% 85% 89% 85% 84% 82% 85% 82% 82% 85% 83% 87% 82% 86% 86% 88% 82% 87% 83% 77% 84% 85% 77% 86% 88% 87% 80% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.3982384
GSM549102patient 115, normal, homogenized [OPG study]8.434785
GSM549104patient 119, normal, homogenized [OPG study]7.5713377
GSM549108patient 138, normal, homogenized [OPG study]8.3160185
GSM549119patient 077, normal, homogenized [OPG study]8.1820283
GSM549133patient 032, cancer, homogenized [OPG study]8.560985
GSM549139patient 042, cancer, homogenized [OPG study]8.2900183
GSM549099patient 107, normal, homogenized [OPG study]8.4326685
GSM549109patient 139, normal, homogenized [OPG study]8.284184
GSM549110patient 046, normal, homogenized [OPG study]8.319484
GSM549114patient 063, normal, homogenized [OPG study]8.3785884
GSM549122patient 082, normal, homogenized [OPG study]8.1068882
GSM549134patient 033, cancer, homogenized [OPG study]8.0008181
GSM549136patient 036, cancer, homogenized [OPG study]7.9376580
GSM549140patient 044, cancer, homogenized [OPG study]8.3075183
GSM549111patient 047, normal, homogenized [OPG study]7.9915781
GSM549113patient 057, normal, homogenized [OPG study]8.4772584
GSM549132patient 031, cancer, homogenized [OPG study]8.604586
GSM549137patient 038, cancer, homogenized [OPG study]8.475785
GSM549142patient 047, cancer, homogenized [OPG study]8.6602189
GSM549100patient 110, normal, homogenized [OPG study]8.4756385
GSM549107patient 135, normal, homogenized [OPG study]8.3642484
GSM549115patient 068, normal, homogenized [OPG study]8.2241382
GSM549116patient 072, normal, homogenized [OPG study]8.4791985
GSM549120patient 078, normal, homogenized [OPG study]8.0933682
GSM549131patient 030, cancer, homogenized [OPG study]8.23882
GSM549118patient 074, normal, homogenized [OPG study]8.466985
GSM549129patient 027, cancer, homogenized [OPG study]8.2311383
GSM549123patient 088, normal, homogenized [OPG study]8.7460887
GSM549124patient 006, cancer, homogenized [OPG study]7.9691882
GSM549126patient 015, cancer, homogenized [OPG study]8.5883786
GSM549128patient 025, cancer, homogenized [OPG study]8.5803986
GSM549103patient 117, normal, homogenized [OPG study]8.7294588
GSM549117patient 073, normal, homogenized [OPG study]8.1862382
GSM549138patient 041, cancer, homogenized [OPG study]8.7666787
GSM549141patient 045, cancer, homogenized [OPG study]8.3052183
GSM549130patient 028, cancer, homogenized [OPG study]7.53377
GSM549101patient 111, normal, homogenized [OPG study]8.3364184
GSM549105patient 128, normal, homogenized [OPG study]8.4668385
GSM549106patient 134, normal, homogenized [OPG study]7.6410477
GSM549112patient 048, normal, homogenized [OPG study]8.6639786
GSM549125patient 011, cancer, homogenized [OPG study]8.84488
GSM549127patient 024, cancer, homogenized [OPG study]8.7178287
GSM549135patient 035, cancer, homogenized [OPG study]8.0075880